AstraZeneca CEO says AI is reshaping drug development — and helping boost the odds of success
CNBC · View original source
AstraZeneca CEO Pascal Soriot said artificial intelligence is helping drugmakers develop medicines faster and make smarter decisions throughout the research process.
"The value of AI in our industry… [+1432 chars]